Objective: The objective of this study was to determine whether automated titration of the fraction of inspired oxygen (FiO) increases the time spent with oxygen saturation (SpO) within a predetermined target SpO range compared with manually adjusted high-flow oxygen therapy in postoperative cardiac surgical patients managed in the intensive care unit (ICU).
Design: Single-centre, open-label, randomised clinical trial.
Setting: Tertiary centre ICU.
Participants: Recently extubated adults following elective cardiac surgery who required supplemental oxygen.
Interventions: Automatically adjusted FiO (using an automated oxygen control system) compared with manual FiO titration, until cessation of oxygen therapy, ICU discharge, or 24 h (whichever was sooner).
Main Outcome Measures: The primary outcome was the proportion of time receiving oxygen therapy with the SpO in a SpO target range of 92-96 %.
Results: Among 65 participants, the percentage of time per patient spent in the target SpO range was a median of 97.7 % (interquartile range: 87.9-99.2 %) and 91.3 % (interquartile range: 77.1-96.1 %) in the automated (n = 28) and manual (n = 28) titration groups, respectively. The estimated effect of automated FiO, compared to manual FiO titration, was to increase the percentage of time spent in the target range by a median of 4.8 percentage points (95 % confidence interval: 1.6 to 10.3 percentage points, p = 0.01).
Conclusion: In patients recently extubated after cardiac surgery, automated FiO titration significantly increased time spent in a target SpO range of 92-96 % compared to manual FiO titration.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11282340 | PMC |
http://dx.doi.org/10.1016/j.ccrj.2024.01.001 | DOI Listing |
Alzheimers Dement
December 2024
UIPS, CHANDIGARH, Punjab, India.
Background: Alzheimer's disease is a brain disorder that causes neurodegeneration and is linked with insulin resistance at molecular, clinical, and demographic levels. Defective insulin signaling promotes Aβ aggregation and accelerates Aβ formation in the brain leading to Type III diabetes.
Objective: The objective of this research project is to demonstrate a linkage if any between the risk of developing Alzheimer's disease and insulin resistance.
Alzheimers Dement
December 2024
George Washington University School of Medicine and Health Sciences, Washington, D.C., DC, USA.
Background: Stress associated with caregiving for a person with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/RD) has negative health implications. However, little is known about the implications of stress on non-Hispanic Black (NHB) informal male caregivers. This study aims to examine the relationship between sleep, depression, and cognitive function in a sample of NHB informal male caregivers in the metropolitan Washington, D.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
IPSIBAT (CONICET/National University of Mar del Plata), Mar del Plata, Buenos Aires, Argentina.
Background: In 2020, we developed LABPSI, a cognitive stimulation web lab. Usability analysis in MCI and healthy participants have already been studied, and currently, we performed it with acquired brain injuries (ABI) participants, as they can rehabilitate their cognitive symptoms and prevent the progression to dementia. Usability can be considered the ease of use of a certain product for a specific aim by a particular population.
View Article and Find Full Text PDFIntroduction: Among persons living with Alzheimer's Disease and Related Dementias (PwD), ∼25% are hospitalized yearly, during which >95% of their time is spent in bed, leading to functional decline for 50% of hospitalized PwD. Hospital-based exercise interventions are a proposed strategy to mitigate this risk of hospital-associated functional decline. However, the applicability of hospital-based exercise intervention trials for PwD is poorly understood.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Bonn-Aachen International Center for IT (b-it), Bonn, Germany.
Background: Alzheimer's Disease (AD) is associated with sleep disturbances. Moreover, individuals with sleep disturbances have been reported to have a higher risk for developing AD. The measurement of sleep behavior therefore opens the opportunity for a potential digital biomarker of AD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!